Investors demanded more clarity from German healthcare group Fresenius SE on Friday regarding its plans to cede strategic control over dialysis group Fresenius Medical Care. "The volatility at Fresenius Medical Care seems to repeatedly overshadow the recent positive operating developments at Fresenius and is also deterring many potential shareholders from investing in Fresenius," said Hendrik Schmidt, corporate governance expert at fund manager DWS. Though the change to FMC's legal structure and the deconsolidation of Fresenius mark a first step, the complete separation is still pending and there is no clear timeline for the move, Schmidt said.
Seacoast Climb announced its opening in Rye, inviting climbers to bouldering gym at Airfield Place.
Just a quick reminder that every Republican lawmaker is required to make a day trip to the Manhattan criminal courthouse to visit Donald Trump.